1 / 10

PRIVATE SECTOR AND PUBLIC HEALTH: A CONTRADICTON IN TERMS? PHARMACEUTICAL INITIATIVES

PRIVATE SECTOR AND PUBLIC HEALTH: A CONTRADICTON IN TERMS? PHARMACEUTICAL INITIATIVES. Effective Advocacy for Health in Europe OSI/EPHA Conference 3-5 April 2003, Riga, Latvia. SPRING GOMBE GLOBAL ACCESS LIAISON HAI EUROPE. STARTING POINT. Health is a human right

ike
Download Presentation

PRIVATE SECTOR AND PUBLIC HEALTH: A CONTRADICTON IN TERMS? PHARMACEUTICAL INITIATIVES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PRIVATE SECTOR AND PUBLIC HEALTH: A CONTRADICTON IN TERMS?PHARMACEUTICAL INITIATIVES Effective Advocacy for Health in Europe OSI/EPHA Conference 3-5 April 2003, Riga, Latvia SPRING GOMBE GLOBAL ACCESS LIAISON HAI EUROPE

  2. STARTING POINT • Health is a human right • Declaration of the Right to Development • UN Convention on the Rights of the Child • Responsibility for health lies ultimately with public sector • Must governments pay for it all – in practice, what, how much, for whom, how? • Rights and responsibilities – including corporate social responsibility

  3. PUBLIC-PRIVATE INTIATIVES • MEDICINES • RESEARCH AND DEVELOPMENT • HEALTH EDUCATION • HEALTH POLICY

  4. MEDICINES • Access to medicines at reduced costs • Medicines for Malaria Initiative • Accelerated Access Initiative • Global Alliance for TB • Global Fund for AIDS, TB, Malaria • Drug donations • Bi-lateral agreements between governments and private sector • Agreements between private sector players

  5. MEDICINES ISSUES • Costs-saving vs. hidden costs • Donations programmes • Bureacracy • Technology transfer • Efficiency • Bureacracy and Administrative Burden • Ethics • Health Policy distortion?

  6. RESEARCH AND DEVELOPMENT • IAVI • GAVI • Medicines for Malaria Venture • Malaria Vaccine Initiative • GATB • Drugs for Neglected Diseases Initiative • Institute for One World Health

  7. RESEARCH AND DEVELOPMENT • ISSUES • Priorities • Universities (public and private) • Public facilities • Private Sector (and public money) • Private sector influence • Market failures • Funding for R&D • Bias? • Intellectual property `rights´ and protection

  8. HEALTH EDUCATION • ISSUES • Direct to Consumer Advertising • Selectivity • Patient Awareness • Patient Self-Advocacy • Rational drug use • Rational prescription • Medicalisation of society

  9. HEALTH POLICY • ISSUES • Social contracts for health (Public Health Equity) • International – WHO, WIPO, WTO, World Bank • National – lobby, pressure, influence • Ethical policy • Rational drug use • Affordability • Market failures

  10. HEALTH POLICY • ISSUES (cont´d) • Discrimination • Verticality • Sustainability • Health burden • Policy distortions • Accountability and responsibility

More Related